mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.3 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.3 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.3 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.3 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.074 |
0.3 |